Bayer completes carbon nanotubes licence agreement with Hyperion

16 March 2011 12:28  [Source: ICIS news]

LONDON (ICIS)--Bayer MaterialScience (BMS) has completed a patent licence agreement for the use of carbon nanotubes with US-based company Hyperion Catalysis International, the German chemicals company said on Wednesday.

BMS said the agreement will strengthen its position in developing new areas of application for its carbon nanotubes, Baytubes.

Financial terms of the agreement were not disclosed.

BMS said Hyperion currently holds a portfolio of patents and patent applications covering a broad technology range, from carbon nanotubes manufacturing to a variety of current and future applications.

“We see high demand for materials with extraordinary material properties,” said Joachim Wolff, a member of the executive committee at BMS.

“This licence with BMS will further leverage Hyperion’s broad patent portfolio and capitalise on the ever-increasing demand for carbon nanotubes,” said David Wohlstadter, Hyperion’s vice president of business development.

“We feel Bayer MaterialScience is well positioned to serve and help increase this demand, while Hyperion remains committed to expanding its own sales and providing its customers with the highest quality carbon nanotube-based products,” he added.

In January 2010, BMS opened a €22m ($31m) pilot facility to manufacture carbon nanotubes at its Leverkusen site in North Rhine-Westphalia, Germany. BMS began construction of the plant, which has an annual capacity of 200 tonnes/year, in January 2009.

($1 = €0.71)

For more on Bayer MaterialScience visit ICIS company intelligence

By: Franco Capaldo
+44 (0)20 8652 3214

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly